Size exclusion chromatography as green support for forced degradation study of adalimumab Cover

.blurhash-client-img { display: none !important; }

Size exclusion chromatography as green support for forced degradation study of adalimumab

Acta Pharmaceutica

Volume 73 (2023): Issue 4 (December 2023)

By: Jelena Kovačić , Daniela Amidžić Klarić , Nikša Turk and Ana Mornar

Open Access

|Dec 2023

Authors

Jelena Kovačić

University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Pharmaceutical Analysis, Zagreb, Croatia

Daniela Amidžić Klarić

University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Pharmaceutical Analysis, Zagreb, Croatia

Nikša Turk

Clinical Hospital Zagreb, Department of Gastroenterology, Zagreb, Croatia

Ana Mornar

ana.mornar@pharma.unizg.hr

University of Zagreb, Faculty of Pharmacy and Biochemistry Department of Pharmaceutical Analysis, Zagreb, Croatia

DOI: https://doi.org/10.2478/acph-2023-0044 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 709 - 721

Accepted on: Nov 24, 2023

Published on: Dec 26, 2023

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

inflammatory bowel disease,

biopharmaceuticals,

size exclusion chromatography,

forced degradation study

Related subjects:

Pharmacy, other

© 2023 Jelena Kovačić, Daniela Amidžić Klarić, Nikša Turk, Ana Mornar, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 73 (2023): Issue 4 (December 2023)Next article